Literature DB >> 7933079

Molecular cloning and characterization of an immunosuppressive and weakly oncogenic variant of Friend murine leukemia virus, FIS-2.

H Y Dai1, A Faxvaag, G I Troseth, H Aarset, A Dalen.   

Abstract

The FIS variant is a weakly leukemogenic, relatively strong immunosuppressive murine retrovirus which was isolated from the T helper cells of adult NMRI mice infected with Friend murine leukemia virus (F-MuLV) complex (FV). Unlike FV, it does not induce acute erythroleukemia but retains the immunosuppressive property of FV and induces suppression of the primary antibody response rapidly and persistently in adult mice. A previous study showed that the FIS variant contains two viral components, a replication-competent virus and a defective virus. In this study, we have biologically purified the FIS variant by end point dilution and we show that the replication-competent virus FIS-2 alone can induce immunosuppression as the parental FIS variant. Most newborn mice infected with FIS-2 developed erythroleukemia, but with an increased latency period compared with that of F-MuLV clone 57. In contrast, FIS-2 induced suppression of the primary antibody response and disease more rapidly than F-MuLV clone 57 in immunocompetent, adult mice. FIS-2 was further molecularly cloned and characterized. Restriction mapping and nucleotide sequence analysis of FIS-2 showed a high degree of homology between FIS-2 and F-MuLV clone 57, suggesting that FIS-2 is a variant of F-MuLV. The striking difference is the deletion of one of the tandem repeats in the FIS-2 long terminal repeat and the single point mutation in the binding sites for core-binding protein and FVa compared with the long terminal repeat of F-MuLV clone 57. Two single point mutations led to the appearance of two extra potential N glycosylation sites in the FIS-2 gag-encoded glycoprotein. Together, the results suggest that FIS-2 represents an interesting murine model to study retrovirus-induced immunosuppression on the basis of its unique combined property of low leukemogenicity and relatively strong and persistent immunosuppressive activity in adult mice.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7933079      PMCID: PMC237134     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins.

Authors:  G J Cianciolo; T D Copeland; S Oroszlan; R Snyderman
Journal:  Science       Date:  1985-10-25       Impact factor: 47.728

2.  Disease specificity of nondefective Friend and Moloney murine leukemia viruses is controlled by a small number of nucleotides.

Authors:  Y Li; E Golemis; J W Hartley; N Hopkins
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

3.  Tissue-specific replication of Friend and Moloney murine leukemia viruses in infected mice.

Authors:  L H Evans; J D Morrey
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

4.  Two different factors act separately or together to specify functionally distinct activities at a single transcriptional enhancer.

Authors:  D DeFranco; K R Yamamoto
Journal:  Mol Cell Biol       Date:  1986-04       Impact factor: 4.272

5.  Glucocorticoid responsiveness of the transcriptional enhancer of Moloney murine sarcoma virus.

Authors:  R Miksicek; A Heber; W Schmid; U Danesch; G Posseckert; M Beato; G Schütz
Journal:  Cell       Date:  1986-07-18       Impact factor: 41.582

6.  Polyclonal activation of B-lymphocytes and induction of autoimmunity in retrovirus infected NMRI mice.

Authors:  A Faxvaag; T Moen; A B Dalen
Journal:  Scand J Immunol       Date:  1993-11       Impact factor: 3.487

7.  The tandem direct repeats within the long terminal repeat of murine leukemia viruses are the primary determinant of their leukemogenic potential.

Authors:  L DesGroseillers; P Jolicoeur
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

8.  The mechanism of retrovirus suppression of human T cell proliferation in vitro.

Authors:  E A Copelan; J J Rinehart; M Lewis; L Mathes; R Olsen; A Sagone
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

9.  Friend virus-specific cytotoxic T lymphocytes recognize both gag and env gene-encoded specificities.

Authors:  C A Holt; K Osorio; F Lilly
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

10.  Influence of the murine MHC (H-2) on Friend leukemia virus-induced immunosuppression.

Authors:  R P Morrison; J Nishio; B Chesebro
Journal:  J Exp Med       Date:  1986-02-01       Impact factor: 14.307

View more
  4 in total

1.  Spontaneous priming for anti-viral envelope cytotoxic T lymphocytes in mice transgenic for a murine leukaemia virus envelope gene (Fv4).

Authors:  A Nihrane; J Silver
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

2.  Identification of genetic determinants responsible for the rapid immunosuppressive activity and the low leukemogenic potential of a variant of Friend leukemia virus, FIS-2.

Authors:  H Y Dai; G I Troseth; M Gunleksrud; T Bruland; L A Solberg; H Aarset; L I Kristiansen; A Dalen
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

3.  Suppression of acute anti-friend virus CD8+ T-cell responses by coinfection with lactate dehydrogenase-elevating virus.

Authors:  Shelly J Robertson; Christoph G Ammann; Ronald J Messer; Aaron B Carmody; Lara Myers; Ulf Dittmer; Savita Nair; Nicole Gerlach; Leonard H Evans; William A Cafruny; Kim J Hasenkrug
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

4.  An immunosuppressive murine leukaemia virus induces a Th1-->Th2 switch and abrogates the IgM antibody response to sheep erythrocytes by suppressing the production of IL-2.

Authors:  A Faxvaag; T Espevik; A Dalen
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.